Journal of minimally invasive gynecology

Journal of minimally invasive gynecology
Audio Summaries

Every issue of Journal of minimally invasive gynecology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

342 audio summariesNLM Catalog

Specialties

Journal of minimally invasive gynecology covers research in these specialties.

Recent summaries

The latest articles summarized from Journal of minimally invasive gynecology.

Concomitant Right-Sided Bowel Resection at the Time of Left Colorectal Surgery for Deep Endometriosis: Is It Associated With Increased Major Morbidity? Evidence From 1,058 Patients.

Nov 17, 2026

This retrospective cohort study of 1,058 women undergoing left-sided colorectal surgery for deep endometriosis asked whether adding concomitant right-sided bowel procedures increases early major postoperative morbidity. Major morbidity (Clavien-Dindo ≥IIIb within 30 days) occurred in 13.8% of patients with combined left and right surgery versus 7.3% with left-sided surgery alone, and ileocecal resection was independently associated with major morbidity and pelvic septic complications after adjustment. The association was stronger when ileocecal resection was added to conservative left-sided procedures than to segmental resection, though the small number of events in some subgroups warrants cautious interpretation.

Robotic Myomectomy for High Fibroid Burden: A Multimodal Blood-Sparing Strategy for the Removal of 40 Leiomyomas.

Nov 14, 2026

This case report describes robotic myomectomy for a 25-year-old nulligravid woman with a 1152-cm³ uterus and 40 leiomyomas, including an 8.6-cm dominant lesion. The authors aim to demonstrate that a multimodal blood-sparing strategy can make removal of a high fibroid burden feasible while minimizing transfusion risk. The abstract provided is limited to the setting and participant details, so the specific techniques and outcomes are not described here.

Postoperative Hormonal Regimens and Two-Year Ovarian Endometrioma Recurrence Following Laparoscopic Cystectomy: A Weighted Retrospective Cohort Study.

Nov 13, 2026

This retrospective cohort study of 1,121 women who underwent laparoscopic cystectomy for ovarian endometrioma asked whether the type of postoperative hormonal therapy affects 24-month recurrence. Compared with combined oral contraceptives, GnRH agonists and dienogest were associated with substantially lower recurrence hazards (adjusted HRs about 0.41), while dydrogesterone showed a similar trend with less certain estimates. Higher baseline CA-125 and deep infiltrating endometriosis were linked to greater recurrence risk, though the findings are observational and do not establish effects on overall endometriosis control or pain.

Video-Based Coaching in Essentials in Minimally Invasive Gynecologic Surgery (EMIGS): A Randomized Controlled Trial.

Nov 13, 2026

This randomized controlled trial asked whether individualized, video-based coaching improves skill acquisition on the Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) tasks among OB/GYN residents and medical students. Participants who received video feedback on their surgical performance improved their running suture (Task 5) completion time by a median of 250 seconds, versus 60 seconds in controls (p = 0.011), with the largest gains seen in medical students. The authors conclude that video-based coaching may be a useful addition to EMIGS training curricula in residency programs.

General anesthesia or Procedural sedation and analgesia for laparoscopic sterilization; a randomized controlled trial.

Nov 10, 2026

This single-blinded randomized controlled trial asked whether procedural sedation and analgesia (PSA) leads to better postoperative recovery than general anesthesia (GA) in 46 women undergoing laparoscopic sterilization. Recovery at 24 hours (QoR-40) and at one week (RI-10) did not differ between groups, and pain medication use was similar, with no anesthesia-related complications in either arm. PSA did shorten total operating room time (43 vs. 61 minutes, p=0.001), leading the authors to suggest it is a promising, potentially more cost-effective option for low-risk patients, pending further safety research in higher-risk populations.

Intravascular Leiomyomatosis: Benign Histology with Aggressive Behavior.

Nov 5, 2026

This case report describes a 27-year-old woman whose intravascular leiomyomatosis, a rare benign smooth muscle proliferation within vessels, appeared 15 months after laparoscopic leiomyoma excision as a pelvic mass with suspicious MRI features and a necrotic lymph node. The authors ask whether a histologically benign tumor can behave aggressively and mimic malignancy, and they answer yes: histopathology confirmed IVL despite the concerning imaging and surgical findings. They conclude that correlating radiologic, surgical, and pathologic findings is essential for accurate diagnosis and appropriate management.

Management of Retained Products of Conception (RPOC) with Hysteroscopic Morcellator: A Systematic Review and Meta-analysis of Efficacy, Safety, and Procedural Outcomes.

Nov 4, 2026

This systematic review and meta-analysis asks whether hysteroscopic morcellation (HM) is effective and safe for treating retained products of conception (RPOC). Pooling four studies (two RCTs, one prospective, one retrospective), the authors found a complete removal rate of 95.0%, with low pooled rates of complications (7.5% intraoperative, 3.4% postoperative) and de novo intrauterine adhesions (5.2%). They conclude that HM appears highly effective and low-risk, but current evidence is too limited to show it is superior to conventional surgical approaches, so adequately powered comparative trials are needed.

Clinical study of a frameless indomethacin-containing copper intrauterine device combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.

Oct 26, 2026

This single-center prospective study (n=91, 12-month follow-up) asked whether adding a frameless copper IUD to a levonorgestrel-releasing IUS improves safety and efficacy in adenomyosis, and whether indomethacin loading adds benefit. Compared with LNG-IUS alone, both dual-device regimens eliminated complete expulsion and severe downward displacement (vs. 17.24% expulsion with LNG-IUS alone), and the indomethacin-containing copper IUD (Group C) produced the greatest reductions in uterine volume, menstrual blood loss, and pain scores with the fewest irregular bleeding events. Given the small sample and non-randomized allocation by patient preference, the authors present the dual-device approach as a promising uterus-sparing option for patients at high risk of IUD expulsion, pending larger confirmatory trials.

S2 Sacral root Schwannoma: Laparoscopic Excision with ICG.

Oct 23, 2026

This case report describes laparoscopic excision of a 3-cm left S2 sacral root schwannoma in a 63-year-old woman, using intravenous indocyanine green (ICG) fluorescence to aid tissue differentiation. The authors asked whether ICG could improve surgical precision, and they observed that the schwannoma was hypofluorescent rather than the hyperfluorescent pattern previously reported for tumors. At 6-month follow-up, pain had improved, reflexes were intact, and MRI showed no residual mass, suggesting that a stepwise nerve-sparing approach combined with ICG contrast can be a safe, reproducible option for this rare condition.

Outcomes and Feasibility of Robotic Pelvic Exenteration for Palliative and Mixed Intent.

Oct 23, 2026

This retrospective case series of 11 patients asks whether robotic-assisted pelvic exenteration is technically feasible when performed with palliative intent for recurrent or advanced gynecologic cancers. Although intended for symptom relief, five cases were reclassified as mixed intent after pathology showed R0 margins or limited disease, and R0 resection was achieved in 9 of 11 patients. Perioperative morbidity was substantial (63.6% complications), and 12-month overall survival was 83.3% based on a single death, so the authors conclude the approach is feasible but that symptomatic benefit and long-term outcomes require prospective study.

Listen to Journal of minimally invasive gynecology

14-day free trial. Every new article, summarized in ~3 minutes.